ONWARD Medical NV
F:63E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
Tsingtao Brewery Co Ltd
F:TSI
|
CN |
|
E
|
EVI Industries Inc
AMEX:EVI
|
US |
|
M
|
Metso Outotec Corp
F:M6Q
|
FI |
|
S
|
Singapore Airlines Ltd
XBER:SIA1
|
SG |
Balance Sheet
Balance Sheet Decomposition
ONWARD Medical NV
ONWARD Medical NV
Balance Sheet
ONWARD Medical NV
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
9
|
15
|
6
|
89
|
62
|
30
|
60
|
68
|
|
| Cash |
9
|
15
|
6
|
89
|
42
|
4
|
12
|
9
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
20
|
26
|
48
|
59
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
3
|
1
|
1
|
2
|
2
|
|
| Total Current Assets |
9
|
15
|
7
|
92
|
64
|
31
|
64
|
74
|
|
| PP&E Net |
1
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
1
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
| Intangible Assets |
0
|
6
|
5
|
8
|
8
|
8
|
8
|
7
|
|
| Goodwill |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Assets |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
10
N/A
|
23
+144%
|
14
-39%
|
105
+639%
|
77
-27%
|
44
-43%
|
76
+75%
|
85
+11%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
1
|
1
|
4
|
5
|
4
|
7
|
7
|
|
| Total Current Liabilities |
2
|
3
|
3
|
6
|
8
|
7
|
9
|
11
|
|
| Long-Term Debt |
17
|
34
|
42
|
13
|
14
|
16
|
14
|
13
|
|
| Deferred Income Tax |
0
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
4
|
5
|
|
| Total Liabilities |
20
N/A
|
38
+93%
|
46
+21%
|
22
-52%
|
24
+8%
|
26
+7%
|
28
+9%
|
29
+4%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
4
|
4
|
4
|
5
|
7
|
|
| Retained Earnings |
10
|
18
|
34
|
76
|
107
|
141
|
176
|
215
|
|
| Additional Paid In Capital |
0
|
3
|
3
|
155
|
155
|
155
|
218
|
264
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
10
N/A
|
15
-45%
|
32
-115%
|
83
N/A
|
53
-36%
|
18
-66%
|
48
+168%
|
55
+15%
|
|
| Total Liabilities & Equity |
10
N/A
|
23
+144%
|
14
-39%
|
105
+639%
|
77
-27%
|
44
-43%
|
76
+75%
|
85
+11%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
30
|
30
|
30
|
30
|
30
|
30
|
45
|
56
|
|